Ibrutinib-associated symptomatic intracerebral haemorrhage following IV thrombolysis for acute ischaemic stroke

Acta Neurol Belg. 2022 Aug;122(4):1111-1113. doi: 10.1007/s13760-022-01935-y. Epub 2022 Mar 28.

Authors

Katrijn Madou¹, Sofie Carrette², Marjan Acou³, Veerle De Herdt⁴, Dimitri Hemelsoet⁴

Affiliations

¹ Master of Medicine, Ghent University, Corneel Heymanslaan 10, 9000, Ghent, Belgium. [email protected].
² Department of Head and Skin, Ghent University Hospital, Ghent, Belgium.
³ Department of Diagnostic Sciences, Ghent University Hospital, Ghent, Belgium.
⁴ Department of Neurology, Ghent University Hospital, Ghent, Belgium.

PMID: 35344193
DOI: 10.1007/s13760-022-01935-y

No abstract available

Keywords: Acute ischaemic stroke; IV thrombolysis; Ibrutinib; Symptomatic intracranial haemorrhage.

Publication types

Letter

MeSH terms

Adenine / analogs & derivatives
Brain Ischemia* / drug therapy
Cerebral Hemorrhage / chemically induced
Cerebral Hemorrhage / diagnostic imaging
Fibrinolytic Agents / therapeutic use
Humans
Ischemic Stroke*
Piperidines
Stroke* / drug therapy
Thrombolytic Therapy / adverse effects
Tissue Plasminogen Activator

Substances

Fibrinolytic Agents
Piperidines
ibrutinib
Tissue Plasminogen Activator
Adenine